Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of two 25 mg tablets vs one 50 mg tablet of daridorexant in healthy Japanese males
jRCT2071220009Phase 1Completed
- Sponsor
- Idorsia
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of daridorexant in Insomnia (2 arms), sponsored by Idorsia. Primary endpoints: Cmax and AUC0-t. Started May 2022; status: completed.
02
Drugs
daridorexant
03
Conditions
Insomnia
Beyond the preview
Go deeper on jRCT2071220009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071220009.